Agilent Technologies Inc (MIL:1A)
€ 122.18 0 (0%) Market Cap: 36.21 Bil Enterprise Value: 37.26 Bil PE Ratio: 28.59 PB Ratio: 6.71 GF Score: 96/100

Agilent Technologies Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 04:40PM GMT
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Good morning. We're going to kick it off with our next presentation, Agilent Technologies.

Before I turn it over to Mike, just a quick reminder, if people have questions to submit them on the website for the Q&A.

And with that, I'll turn it over to Mike.

Michael R. McMullen
Agilent Technologies, Inc. - CEO, President & Director

Tycho, thanks very much. And while I'm sure all of you are missing the hallways of the St. Francis, really glad you could join us today in this call. And I'm very excited to be here today to share with you the Agilent story.

There are 3 parts to my story today. First one is just want to remind you of the Agilent shareholder value-creation model, and then as we move forward, how we're going to continue to work that model we're delivering for our shareholders today. Then we're going to talk about growth, how we're going to continue to enable the growth of this company, what are our plans to even accelerate our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot